ライフサイエンスコーパス: adjust

1 5) (unadjusted) and 1.80 (95% CI 1.04-3.13) (adjusted).

2 >=65 years old, there were no differences in adjusted 1-year risks of adverse outcomes across hospita

3 Median hospital-level risk-adjusted 30-day home time was 24.0 days (range, 15.3-29.

4 ); III) Influence the manual ongoing action: adjust (7), or stop the resident's manual activity (8);

5 The cumulative incidence of PCR-adjusted ACPR at Day 42 was 96.1% (95% confidence interv

6 admission was associated with decreased risk-adjusted acute hospital mortality (odds ratio, 0.94; 95%

7 s (95% confidence interval = 60-85%); chance-adjusted agreement was determined to be 0.44 (95% confid

8 After adjusting all data for inflation, the reimbursement rate

9 s showed no association with SCC in crude or adjusted analyses (HR 0.98, 95% CI 0.73-1.31, p=0.89).

10 The IPTW-adjusted analyses showed no association between prenatal

11 In adjusted analyses, for every 10 telestroke consults requ

12 In multivariable adjusted analyses, there was no significant association

13 In adjusted analysis, patient factors associated with incre

14 sitivity and the dynamic linear range can be adjusted and detection limits at a picogram level can be

15 We suggest that this adjusted and further adaptable metric, which included th

16 defined values or haemoglobin less than age-adjusted and sex-adjusted values), clinical malaria (inf

17 9) (unadjusted) and 2.05 (95% CI 1.16-3.64) (adjusted) and at a threshold of 9.8 HRs were 1.85 (95% C

18 demonstrated similar discriminative ability (adjusted area under the curve = 0.69) and calibration ch

19 We evaluated multivariable-adjusted associations with IOP using linear regression a

20 ove that the output power can be effectively adjusted at real-time in response to acceleration change

21 The adjusted AUROC for discriminating between healthy and gl

22 both baseline and 26 weeks in the BGM group (adjusted between-group difference, -0.37% [95% CI, -0.66

23 erative mortality for MaSBO with an optimism-adjusted Brier score of 0.114 and area under the curve o

24 population attributable fractions (PAF) were adjusted by age, sex, all other risk factors and socioec

25 migrate into cortex, where their numbers are adjusted by programmed cell death.

26 In an adjusted Cox model, brincidofovir exposure remained asso

27 In the most adjusted Cox models, the risk of HF was 39% and 62% lowe

28 nt was overall survival (OS) evaluated using adjusted Cox regression analysis.

29 sociated with a 3% (95% CI, 0.96-0.97) lower adjusted critical illness mortality within a non-minorit

30 The median adjusted Ct value for asymptomatic children was 10.3 cyc

31 The change point of risk-adjusted cumulative sum was 3.12 for competency assessme

32 JBL group experienced greater BMI loss [mean adjusted difference (95% confidence interval, CI) -3.1 k

33 1.9) kg/m, P < 0.001] and HbA1c change [mean adjusted difference -0.5% (95% CI -0.9 to -0.2); P < 0.0

34 minutes in the intervention group (baseline-adjusted difference [95% confidence interval] -1.91 minu

35 IPSS (mean 6.3 for TURP and 6.4 for ThuVARP; adjusted difference in means 0.28, -0.92 to 1.49).

36 , 20/63) in the vitrectomy group at 4 weeks (adjusted difference, -11.2 [95% CI, -18.5 to -3.9], P =

37 and in 5.2% (75 of 1456) in the 5-day group (adjusted difference, 0.7 percentage points; 95% confiden

38 71.0 (Snellen equivalent, 20/40) at 2 years (adjusted difference, 2.7 [95% CI, -3.1 to 8.4], P = .36)

39 d 46.5% [95% CI, 44.8%-48.1%], respectively; adjusted difference, 4.4 [95% CI, 2.6-6.2]; P < 0.001) a

40 aucoma (mean, 34.7% and 38.5%, respectively; adjusted difference, 4.8 [95% CI, 1.6-8.1]; P = 0.005).

41 tively, and noninferiority was demonstrated (adjusted difference: 3.3%; 95% CI: -1.2, 7.8).

42 m 43 State Inpatient Databases to calculate "adjusted" donation rates.

43 ause hospitalization when comparing the risk-adjusted effect of treatment initiation with bevacizumab

44 Used in conjunction with other resources, adjusted estimates will inform public health contingency

45 sion models were used to obtain age- and sex-adjusted estimates.

46 Mean adjusted excess weight loss 3 years after SG amounted to

47 tching, and inverse probability weighting to adjust for confounding by severity of illness lead to bi

48 of analysis, with crossed random effects to adjust for correlation between fellow eyes and repeated

49 ty of treatment weighting (IPTW) was used to adjust for differences between treatment groups for all

50 tests and Cox proportional hazards models to adjust for known adverse prognostic factors.

51 factors in multivariable analyses that also adjust for the complex variance structure of the oral en

52 ison, and a meta-regression was conducted to adjust for use and duration of ADT.

53 tic regression, including a random effect to adjust for within-school clustering, minimisation variab

54 inversions and biosphere models, which were adjusted for a consistent flux definition, showed a high

55 sformed FGF21 and FGF23 serum concentrations adjusted for age, sex and principal components of ancest

56 isk of IE according to streptococcal species adjusted for age, sex, >=3 positive blood culture bottle

57 After we adjusted for age, sex, body mass index, and type-2 diabe

58 We adjusted for age, smoking, body mass index, physical act

59 etween hourly particle metrics and MI cases, adjusted for air temperature and relative humidity.

60 revalence 95% confidence intervals (CI) were adjusted for assay sensitivity and specificity.

61 When adjusted for baseline age, socioeconomic status, and sel

62 11.6 [95% CI, 4.1-19.2]; P=0.01) in a model adjusted for baseline demographics.

63 Estimates of sCFR and IFR, adjusted for bias, were more similar to each other but s

64 After we adjusted for clinical factors, the genetic risk score wa

65 In Cox models adjusted for clinical risk factors, 29 proteins demonstr

66 ht and/or obesity prevalence in the country, adjusted for cluster and sample weight.

67 Analyses were adjusted for confounding by time, cluster effects, and p

68 We used Cox proportional hazards models, adjusted for high-dimensional propensity scores, to gene

69 m magnetic resonance imaging (3T, FLAIR) and adjusted for intracranial volume (ICV).

70 A Cox proportional hazards model adjusted for known clinical predictors showed that serum

71 Multivariable analysis adjusted for late gadolinium enhancement.

72 tion predicting time to all-cause mortality, adjusted for Meta-Analysis Global Group in Chronic Heart

73 We performed analysis of covariance, adjusted for model for end-stage liver disease at time o

74 When adjusted for percentage total weight loss and demographi

75 sed the intention-to-treat (ITT) population, adjusted for potential confounders at patient level (sex

76 3,446) years using linear regression models adjusted for potential confounders.

77 with cancer risk using Cox regression models adjusted for potential confounders.

78 When adjusted for prespecified baseline variables, the odds r

79 d to controls in linear mixed-effects models adjusted for repeated measures, experimental variables,

80 hysical activity volume at 3-month follow-up adjusted for sex, 5-year age group, and general practice

81 erences in risk factors among patient groups adjusted for sociodemographic factors and age-adjusted t

82 In analysis adjusted for sociodemographics and BV, enrichment of vag

83 gation of breast and ovarian cancer and were adjusted for the family-specific ascertainment schemes.

84 , deaths, and healthcare needs expected, age-adjusted for the Kutupalong-Balukhali Expansion Site age

85 estimates were only slightly attenuated when adjusting for a CAD PRS (odds ratio, 1.26 [95% CI, 1.16-

86 This association was stronger when further adjusting for admission severity (aOR 1.85 95% CI 1.06-3

87 ed to physical functioning (p=5.9e-3), after adjusting for age and cell counts.

88 oughout recovery versus those without, after adjusting for age and sex.

89 Logistic regression analyses adjusting for age, all the sociodemographic factors abov

90 After adjusting for age, disc area, and other confounders, sig

91 After adjusting for age, gender, and cardiovascular risk facto

92 After adjusting for age, gender, baseline BCVA and AMD subtype

93 s of death did not differ by ethnicity, when adjusting for age, sex and comorbidities, black patients

94 hese associations remained significant after adjusting for age, sex, body mass index, type 2 diabetes

95 d using robust logistic quantile regression, adjusting for age, sex, ethnicity, education level, smok

96 In the multivariable analysis adjusting for age, sex, hepatitis B e antigen serostatus

97 In comparison, after adjusting for alcohol consumption, smoking retained its

98 f success in a hypothetical phase III trial, adjusting for biomarker covariates.

99 r 13.0% vs 37.2%) were not significant after adjusting for career duration (P = .083, .459, and .113,

100 Once adjusting for clustering and age, the difference in decl

101 multilevel random effect regression analyses adjusting for clustering in health centres.

102 with reductions in health expenditures after adjusting for confounders, especially in inpatient and e

103 n particle metric in two-pollutant models by adjusting for copollutants, including particulate matter

104 in Black children slightly attenuated after adjusting for cord plasma creatinine (P = 0.05).

105 Multivariate Cox regression adjusting for demographics and clinical measures of visi

106 After adjusting for depression symptoms, the PTSD findings in

107 ypo- or hyperthyroidism versus euthyroidism, adjusting for depressive symptoms at baseline, age, sex,

108 ere more likely to have high MLVI even after adjusting for deprivation (adjusted odds ratio 4.0 95% c

109 variable analysis for NGS-positive patients, adjusting for disease risk and donor group, RIC was sign

110 After adjusting for disease severity and relevant clinical fac

111 ders in HIV-positive people in South Africa, adjusting for HIV treatment outcomes.

112 After adjusting for imbalances in baseline and implementation

113 After adjusting for inflation, Medicare reimbursement rates in

114 Adjusting for mental disorders, three significant associ

115 each subsequent examination after baseline, adjusting for multiple colonoscopies within individuals.

116 e fitted mixed-effects Cox regression models adjusting for multiple pregnancies per individual.

117 n those who passed their first attempt after adjusting for multiple surgeon characteristics (adjusted

118 These associations were attenuated after adjusting for other shared risk factors, with a signific

119 cation (OR = 3.94; 95%CI: 2.74, 5.67), after adjusting for other TB risk factors (age, sex, BCG-vacci

120 Cox proportional hazards analysis, after adjusting for patient and hospital characteristics and w

121 reatments, and findings were maintained when adjusting for patient's age, sex, and total intracranial

122 ficant predictor of facial recognition after adjusting for potential confounders including glaucoma s

123 After adjusting for potential confounders, the RRs (95% CIs) o

124 tion (1.41 [95% CI, 1.14-1.73]), but further adjusting for pre-MI health status (1.25 [95% CI, 1.00-1

125 hemotherapy participants than controls after adjusting for previous vaccine doses (P < .001).

126 ious sensitivity analyses, including further adjusting for property values and performing exploratory

127 tients with a history of autoimmune disease, adjusting for race and body mass index.

128 SD risk across the entire range of GAs while adjusting for sex and size for GA.

129 l disparity in KT waitlisting persists after adjusting for social determinants of health (eg, cultura

130 Adjusting for sociodemographic characteristics did not a

131 After adjusting for sociodemographic/medical history, BMI (Odd

132 ct hospital catchment for malaria admissions adjusting for spatial distance.

133 ; hazard ratio: 1.74:95%CI: 1.16-2.59) after adjusting for the baseline confounders.

134 ssessed with a linear mixed regression model adjusting for the effects of baseline MD and age, catara

135 These findings persisted after adjusting for the presence of late gadolinium enhancemen

136 We used similarly adjusted generalised linear models to examine associatio

137 usting for multiple surgeon characteristics (adjusted hazard rate 2.98, 95% CI 1.85-4.81).

138 onal-hazards regression model found that the adjusted hazard rate for loss-of-license actions for sur

139 ansplantation were associated with increased adjusted hazard ratio (aHR) for MACCE or all-cause morta

140 Survival also improved in plasma recipients (adjusted hazard ratio (HR), 0.34; 95% CI, 0.13-0.89; chi

141 ents had lower rates of long-term mortality (adjusted hazard ratio (HR), 0.473; 95% CI, 0.392-0.571;

142 ence in both uni- and multivariate analysis (adjusted hazard ratio 3.05 and 1.88, respectively).

143 eriod within the first month posttransplant (adjusted hazard ratio [aHR]: 2.493.494.89, P < 0.001), b

144 ciated with 5-year cardiovascular mortality (adjusted hazard ratio [HR]: 2.18 [95% CI: 1.13 to 4.23]

145 In contrast, the adjusted hazard ratio for major amputations was 1.00 (95

146 ficantly increased risk for all-cause death (adjusted hazard ratio for moderate and severe degrees of

147 The adjusted hazard ratio was highest in patients who underw

148 arm, which was not significantly different (adjusted hazard ratio, 1.07; 95% confidence interval, 0.

149 atic decompensations in patients with DACLD (adjusted hazard ratio, 1.4; 95% confidence interval: 0.9

150 redictive of a first hepatic decompensation (adjusted hazard ratio, 3.7; 95% confidence interval: 1.1

151 : 2.7, 20.2; P < .001) and those with DACLD (adjusted hazard ratio, 3.8; 95% confidence interval: 1.7

152 r for mortality in both patients with CACLD (adjusted hazard ratio, 7.4; 95% confidence interval: 2.7

153 001) and all-cause-mortality (7.6% vs. 9.7%; adjusted hazard ratio: 0.61; 95% confidence interval: 0.

154 en had a lower risk of MACE (9.5% vs. 11.2%; adjusted hazard ratio: 0.77; 95% confidence interval: 0.

155 of death or HFH between 30 days and 2 years (adjusted hazard ratio: 0.91 per -5 mm Hg PASP; 95% confi

156 %) were significantly associated with death (adjusted hazard ratio: 1.75; 95% CI: 1.37 to 2.24; p < 0

157 h-dimensional propensity scores, to generate adjusted hazard ratios (aHR).

158 Adjusted hazard ratios (HRs) and 95% CIs were estimated

159 Compared with 2000 to 2004, the adjusted hazard ratios in 2013 to 2016 were 0.73 (95% CI

160 omography (PET), (18)F-flortaucipir PET, and adjusted hippocampal volume (aHCV).

161 ondary endpoints were survival and inflation-adjusted hospital readmission charges.

162 8-1.83); P < 0.0001] or Alzheimer's disease [adjusted HR 1.50 (95% CI, 1.26-1.78); P < 0.0001].

163 ed with a higher risk of all-cause dementia [adjusted HR 1.59 (95% CI, 1.38-1.83); P < 0.0001] or Alz

164 e significantly associated with higher risk (adjusted HR: 3.03; 95% CI: 2.42 to 3.80; p < 0.001).

165 (12.8%) versus nonpaclitaxel devices (15.5%; adjusted HR=0.85 [95% CI, 0.72-1.00], P=0.05).

166 x models were used to estimate multivariable-adjusted HRs between lifetime ovulatory cycles (LOC) and

167 by intensivists working 7+ consecutive days (adjusted ICU length of stay = 2.85 d), care by an intens

168 Model estimates showed 69% (adjusted incidence rate ratio (IRR) 0.31, 95%CI, 0.20-0.

169 eceiving rfMDA than in those receiving RACD (adjusted incidence rate ratio 0.52 [95% CI 0.16-0.88], p

170 rend was seen in 12- to 17-year-old females (adjusted incidence rate ratio [aIRR] 1.12, 95% confidenc

171 trolled case-series method, we estimated age-adjusted incidence rate ratios within 1-7, 8-21, and 1-2

172 ed according to time since diagnosis with an adjusted IRR for 1 to 3 months of 3.1 (95% CI, 2.7-3.6)

173 strate flux relative to demand, continuously adjusting JH(2)O(2) production and, in turn, the rate at

174 sociated with plaintiff verdicts with a mean adjusted jury award of $994 260.

175 ine to 30 days to a greater than GDMT alone (adjusted least squares mean: -4.0 vs. -0.9 mm Hg; p = 0.

176 95% CI, 8.2-74.5), respectively; the placebo-adjusted least-squares between-group difference in mean

177 ears) to pound 18,513 (20 years) per quality-adjusted life year (QALY) gained with V-MMRV; and from p

178 Based on funding per 2017 disability-adjusted life years (DALYs), HIV/AIDS received the great

179 arkers, protocol biopsy yielded more quality-adjusted life years (QALYs) at lower cost.

180 a simulation model that can estimate quality-adjusted life years and costs resulting from improvement

181 vere trauma is the first cause of disability-adjusted life years worldwide, yet most attention has fo

182 ity (eg, healthcare resource use and quality-adjusted life years).

183 ctiveness threshold of US$500 per disability-adjusted life-year (DALY) averted for our main analysis.

184 r-accurate diagnosis) and long term (quality-adjusted life-years [QALYs]).

185 eople and results in 10.5 million disability-adjusted life-years lost globally.

186 correlated with 5.5 average lifetime quality-adjusted life-years lost per patient.

187 Burden of Disease (GBD) super-regions, with adjusted linear and logistic regression analyses examini

188 Adjusted logistic regression models and meta-analyses we

189 journals (p = 0.320, 95% CI - 0.015, 0.046, adjusted mean false discovery rate Open Access = 0.241 v

190 the past 12 months compared to non-migrants (adjusted mean risk = 6.0% versus 9.3%, p = 0.084).

191 3 years in all eyes was similar, as was the adjusted mean VA change, +0.3 letters (95% CI, -1.5 to 2

192 nt variation in rates across hospital sites (adjusted median rate, 11.4%; IQR, 8.9-14.5).

193 1.20; P = 0.063; CI 95% 0.99 to 1.45 in the adjusted model).

194 In the adjusted model, CT, HPV16, HPV53, HPV70, the CD4+/CD8+ r

195 In the adjusted model, factors associated with eGFR <90 mL/min/

196 st quartile (<200 pg/mL) in the age- and sex-adjusted model.

197 In adjusted models, methylation at 20 CpGs was associated w

198 In adjusted models, PN was significantly associated with al

199 In time-dependent covariate adjusted models, post-procedure MALE hospitalization was

200 ptide) levels were examined in multivariable-adjusted models.

201 Risk-adjusted mortality declined with increasing discharge de

202 All AMI risk-adjusted mortality rates also declined from 2006 to 2017

203 arametric g-computation was used to estimate adjusted mortality rates by sex and age.

204 percentile (ie, highest mortality) of fully adjusted mortality, 60% were located in 3 states: Oklaho

205 Adjusted MSPHM survival analyses also found no significa

206 Broth microdilution using standard cation-adjusted Mueller-Hinton broth (BMD) and iron-depleted ca

207 -Hinton broth (BMD) and iron-depleted cation-adjusted Mueller-Hinton broth (ID-BMD), and agar dilutio

208 Heterogeneity was performed adjusting multilevel models.

209 How cells adjust nutrient transport across their membranes is inco

210 nts with an MPP deficit > 20%, multivariable-adjusted odds of developing new significant AKI and MAKE

211 h MLVI even after adjusting for deprivation (adjusted odds ratio 4.0 95% confidence interval, 1.7-10.

212 ciated with female sex in the index patient (adjusted odds ratio [aOR] 1.56 [95% CI 1.38-1.77], p<0.0

213 ear experience of physical (couples' UBL arm adjusted odds ratio [AOR] = 1.00, 95% confidence interva

214 a lower abnormal interpretation rate (AIR) (adjusted odds ratio [AOR], 0.85; P < .001), which remain

215 ificantly associated with preterm birth (age-adjusted odds ratio [aOR], 1.50; 95% confidence interval

216 in genetic testing as a PLD: age >=35 years (adjusted odds ratio [aOR], 1.75; 95% confidence interval

217 re >6 times higher in women with anal hrHPV (adjusted odds ratio [aOR], 6.08 [95% confidence interval

218 roup vs 21 [32%] of 65 in the control group; adjusted odds ratio [OR] 1.74, 95% CI 0.81-3.74).

219 ents in the standard GVHD prophylaxis group (adjusted odds ratio [OR] 3.49 [95% CI 1.60-7.60]; p=0.00

220 Sjogren syndrome made every day a challenge (adjusted odds ratio [OR] 3.81, 95% confidence interval [

221 d with the presence of an endotracheal tube (adjusted odds ratio, 0.13; 95% CI, 0.1-0.2) and urinary

222 0.13; 95% CI, 0.1-0.2) and urinary catheter (adjusted odds ratio, 0.28; 95% CI, 0.1-0.6).

223 pression symptoms between ages 3 to 8 years (adjusted odds ratio, 0.73; 95% confidence interval, 0.57

224 h reduced risk of alcohol-related cirrhosis (adjusted odds ratio, 0.76; P=.0027); conversely, the min

225 scharge delay and was lowest at 48-72 hours (adjusted odds ratio, 0.87; 95% confidence interval, 0.79

226 increased risk of alcohol-related cirrhosis (adjusted odds ratio, 1.30; P=.020).

227 showed a similar, yet nonsignificant trend (adjusted odds ratio, 1.44; 95% confidence interval, .81-

228 asing number of vessels injured per patient (adjusted odds ratio, 1.6 per one-vessel increase [95% CI

229 mber of intravitreal injections (AMD and PCV adjusted odds ratio, 12.1 [P = 0.001] and 12.5 [P = 0.00

230 Higher injury grade (adjusted odds ratio, 2.0 per one-grade increase [95% con

231 d baseline VA of 20 logMAR letters or fewer (adjusted odds ratio, 3.8 and 10.6 for AMD and PCV, respe

232 Adjusted odds ratios (95% CI; p-value) for infant deaths

233 requent AECRS with statistically significant adjusted odds ratios (aORs) after controlling for age, r

234 The age, site, and co-infection adjusted odds ratios (aORs) for moderate-to-severe diarr

235 Age-standardized detection rates and age-adjusted odds ratios (ORs) were calculated.

236 Adjusted odds ratios for vaccination with 1, 2, and 3 do

237 After adjusting on age and Sequential Organ Failure Assessment

238 8 participants, 19 countries, 13 languages), adjusting only for current and local currencies while re

239 6) and added a significant emotional burden (adjusted OR 2.22, 95% CI 1.49 to 3.31).

240 = 7.98 x 10(-22)) and replication datasets (adjusted OR = 1.55, P = 0.06) with a loss-of-function mu

241 We also observe an association in discovery (adjusted OR = 2.61, P = 7.98 x 10(-22)) and replication

242 e likely to be admitted for unstable angina (adjusted OR, 1.46 [95% CI, 1.04-2.05]).

243 Adjusted ORs for the impact of dry eye were generally lo

244 Between 2000-2003 and 2012-2015, the adjusted overall mortality decreased by 24% (hazard rati

245 Overall, lactobacilli suppressed IL-6 (adjusted p < 0.001) and IL-8 (adjusted p = 0.0170) respo

246 ppressed IL-6 (adjusted p < 0.001) and IL-8 (adjusted p = 0.0170) responses to G. vaginalis.

247 with stroke recovery scores (R(2)=0.38-0.73, adjusted P<0.05).

248 o vaccine recipients with no late boost (all adjusted p<0.05, except for the polyfunctionality score

249 livery compared to CS with or without labor (adjusted p-value 1.57 x 10(-11) and 3.70 x 10(-13), resp

250 TREAP, that combines betweenness values and adjusted p-values for target inference.

251 y, provided moderate-certainty evidence that adjusting panel size for case mix and adding clinical co

252 Adjusted path analysis logistic regression models were u

253 egression analysis was used to estimate risk-adjusted predictors of post-transplant mortality.

254 ginal structural models, we calculated model-adjusted prevalence rates and ratios to determine the ch

255 hout health insurance (24.2%) (multivariable-adjusted prevalence ratio, 1.40 [95% CI, 1.08-1.80], 1.4

256 For girls, the adjusted probability of violence outcomes was estimated

257 The adjusted proportion (95% confidence interval) of LTs pai

258 95% confidence interval: 0.71, 0.92, and BH-adjusted Ptrend = 0.001; and for EA, quintile5 vs. 1 haz

259 95% confidence interval: 0.64, 0.98, and BH-adjusted Ptrend = 0.1).

260 In adjusted regression analyses, we examined associations o

261 Baseline stroke severity adjusted regression model showed that changes within 96-

262 Adjusted regression models and a meta-analysis were perf

263 nt falls (>=2 falls) before evaluation using adjusted regression.

264 11.0% point (95% CI: -18.1, -3.8; P < 0.01) adjusted relative reduction in anemia prevalence and a m

265 The adjusted relative risk for women versus men of developin

266 99 cells/uL (9.2%) between months 18 and 30 (adjusted relative risk, 0.30 [95% confidence interval, .

267 y in patients with both acute kidney injury (adjusted relative risk, 2.38; 95% CI, 1.75-2.98) and sur

268 risk, 2.38; 95% CI, 1.75-2.98) and surgery (adjusted relative risk, 6.17; 95% CI, 4.81-7.97).

269 mparison group (10 per 10 000 person-years), adjusted results showed no evidence of any association b

270 ource of contention is CMS's proposal not to adjust risk for race in their OPO outcome.

271 .7% with intervention vs 27.3% with placebo; adjusted risk difference, 0.03; 95% CI, -0.1 to 0.2; P =

272 iviral therapy was associated with decreased adjusted risk of all-cause mortality (13 studies, n = 36

273 parison with those who remained on dialysis, adjusted risk of death 12 months after transplantation i

274 p reported at least 1 serious adverse event (adjusted RR, 1.72 [95% CI, 0.7 to 4.3]).

275 Norepinephrine adjusts sensory processing in cortical networks and gate

276 intile with the lowest risk- and reliability-adjusted serious complication rates for each operation.

277 Adjusting size and zeta potential may allow investigator

278 16, with the highest increases in population-adjusted spending by public insurance.

279 Adjusted state-specific hemodialysis mortality rates wer

280 This makes it possible to automatically adjust stimulus configurations based on an individual's

281 ure and ADHD in each study, and combined all adjusted study-specific effect estimates using random-ef

282 Only 18 (3.1%) counties had adjusted surgery rates of 68.0% to 74.6%, which was asso

283 djusted for sociodemographic factors and age-adjusted temporal trends were investigated using logisti

284 We suggest that hydrodynamic instabilities adjust the angular-momentum distribution at mid-latitude

285 in pH or ionic strength) can be employed to adjust the packing degree and the spatial position of mi

286 ated with VI in the eye-level analysis after adjusting the inter-eye correlation.

287 By adjusting the tile geometry to gain control over the cur

288 actful environmental factors to which plants adjust their growth and development.

289 sociates, demonstrating that individuals can adjust their social behaviours to match experienced cond

290 d the calibration parameters are dynamically adjusted to any change in pH and temperature during the

291 reaction models were sequentially built and adjusted to experimental data to describe changes in con

292 and observed that neurobehavioural responses adjusted to match these statistics, a process that requi

293 These models were adjusted to reproduce data collected from the brain.

294 totyping of customized electrode arrays well adjusted to specific anatomical environments, functions

295 ed and fully validated in analytical ranges, adjusted to their recommended dietary allowance values.

296 elial integrity is vital for homeostasis and adjusted to tissue demands.

297 n profile of the polymer-length distribution adjusts to changes in protomer concentration and affinit

298 etical distributions are then used to derive adjusted uncertainty estimates in the reported effect es

299 r haemoglobin less than age-adjusted and sex-adjusted values), clinical malaria (infection and sympto

300 hen applied this method to calculate climate-adjusted water quality guideline values (GVs) for two re